Cyclic heptapeptide anti-inflammatory agent

Details Cyclic heptapeptide anti-inflammatory agent Cyclic heptapeptide anti-inflammatory agent

1995-05-23

1997-01-14

Rollins, John W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530317, 530321, 435 713, 4352521, 4352535, 4352536, A61K 3812, A61K 3800

Patent

active

055939600

ABSTRACT:
A cyclic heptapeptide anti-inflammatory agent named cyclomarin-A is disclosed. Cyclomarin-A is produced by a specific marine actinomycete. The cyclomarin-A producing bacterium is isolated from sediment located in marine estuaries in and around San Diego, Calif. Fermentation of the isolated bacterium in saltwater-based media produces cyclomarin-A as a secondary by-product. The cyclomarin-A is useful as an anti-inflammatory agent.

REFERENCES:
patent: 4331594 (1982-05-01), Hamill et al.
patent: 4342829 (1982-08-01), Kastner et al.
patent: 4384043 (1983-05-01), Martin et al.
patent: 4452782 (1984-06-01), Takemoto et al.
patent: 4608343 (1986-08-01), Labeda et al.
patent: 4677071 (1987-06-01), Lee et al.
patent: 4977083 (1990-12-01), Boeck
patent: 5006466 (1991-04-01), Lam et al.
patent: 5229362 (1993-07-01), Kirst et al.
patent: 5444043 (1995-08-01), Fenical et al.

Affiliated with

Also associated with

Rating

Cyclic heptapeptide anti-inflammatory agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic heptapeptide anti-inflammatory agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic heptapeptide anti-inflammatory agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1388164